What are the diagnosis and treatment options for Bacterial Vaginosis (BV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 21, 2025 • View editorial policy

From the Guidelines

Bacterial vaginosis (BV) should be treated with a 7-day course of oral metronidazole 500mg twice daily, as it is the most effective regimen with a cure rate of 78% 1. The diagnosis of BV is typically made through clinical assessment using Amsel's criteria, which includes symptoms such as vaginal discharge, fishy odor, clue cells on microscopy, and vaginal pH >4.5.

  • The treatment options for BV include: + Oral metronidazole 500mg twice daily for 7 days + Clindamycin vaginal cream 2% applied at bedtime for 7 days + Metronidazole vaginal gel 0.75% applied once daily for 5 days
  • According to the 1998 guidelines for treatment of sexually transmitted diseases 1, oral metronidazole is efficacious for the treatment of BV, resulting in relief of symptoms and improvement in clinical course and flora disturbances.
  • It is essential to note that during treatment, patients should avoid alcohol with metronidazole due to potential disulfiram-like reactions, abstain from sexual intercourse or use condoms, and complete the full treatment course even if symptoms resolve quickly.
  • The goal of treatment is to restore normal vaginal flora balance, which is often disrupted in BV, allowing overgrowth of anaerobic bacteria like Gardnerella vaginalis and Prevotella species 1.

From the FDA Drug Label

A randomized, double-blind, placebo-controlled clinical trial in 235 non-pregnant women was conducted to evaluate the efficacy of tinidazole for the treatment of bacterial vaginosis. A clinical diagnosis of bacterial vaginosis was based on Amsel's criteria and defined by the presence of an abnormal homogeneous vaginal discharge that (a) has a pH of greater than 4. 5, (b) emits a "fishy" amine odor when mixed with a 10% KOH solution, and (c) contains ≥20% clue cells on microscopic examination. Therapeutic cure required a return to normal vaginal discharge and resolution of all Amsel's criteria In patients with all four Amsel's criteria and with a baseline Nugent score ≥4, tinidazole oral tablets given as either 2 g once daily for 2 days or 1 g once daily for 5 days demonstrated superior efficacy over placebo tablets as measured by therapeutic cure, clinical cure, and a microbiologic cure.

The diagnosis of bacterial vaginosis (BV) is based on Amsel's criteria, which include:

  • Abnormal homogeneous vaginal discharge with a pH of greater than 4.5
  • "Fishy" amine odor when mixed with a 10% KOH solution
  • Presence of ≥20% clue cells on microscopic examination The treatment of BV with tinidazole is effective, with therapeutic cure rates of 97.5% for the 2g x 2 days regimen and 97.5% for the 1g x 5 days regimen, as demonstrated in a randomized, double-blind, placebo-controlled clinical trial 2.

From the Research

Diagnosis of Bacterial Vaginosis (BV)

  • BV is a common cause of vaginitis worldwide, associated with serious reproductive health outcomes, including increased risk of preterm birth, sexually transmitted infections, and pelvic inflammatory disease 3.
  • The diagnosis of BV is typically made using standard clinical and laboratory criteria, including vaginal saline wet prep, potassium hydroxide microscopic examinations, Gram's stain, and pH tests 4.
  • DNA probe tests can also be used to diagnose BV, and may indicate that Gardnerella vaginalis may remain after a clinical cure, explaining cases of recurrent disease 4.

Treatment of Bacterial Vaginosis (BV)

  • The current and only FDA-approved treatment regimens for BV are antibiotics, such as metronidazole and clindamycin 3.
  • Oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream have been shown to be effective in treating BV, with similar cure rates 4.
  • Tinidazole has also been used to treat BV, and has been shown to be equivalent to oral metronidazole, intravaginal clindamycin cream, and intravaginal metronidazole tablets in efficacy, with a more favorable side effect profile 5.
  • Alternative strategies for treating BV are being studied, including antimicrobial substances, probiotics, prebiotics, and acidifying agents, as well as new formulation strategies and drug delivery systems 6.

Recurrence and Management of BV

  • BV is associated with high rates of recurrence, with 50-80% of women experiencing a recurrence within a year of completing antibiotic treatment 3.
  • The recurrence of BV may be due to the persistence of Gardnerella vaginalis after treatment, and the failure to reestablish acidic pH and the lactobacillus-dominated commensal flora 6.
  • Behavioral modifications, such as smoking cessation, condom use, and hormonal contraception, may help to prevent recurrence 3.
  • Additional strategies, such as dietary modification, non-medical vaginally applied products, and treatments from medical practices outside of allopathic medicine, are also being considered 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.